Clinical Trial Update: A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

This Phase 3 trial compares adding the dermaPACE device to standard of care versus standard of care alone for diabetic foot ulcers; the current status of the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• dermaPACE

Snippet

Sponsor: SANUWAVE, Inc. | Conditions: Diabetic Foot Ulcers | Phase 3 | Status: UNKNOWN